CRISPR-Cas9-Mediated Silencing of CD44 in Human Highly Metastatic Osteosarcoma Cells

Background/Aims: Metastasis is the major cause of death in patients with osteosarcoma. There is an urgent need to identify molecular markers that promote metastasis. Cluster of differentiation 44 is a receptor for hyaluronic acid (HA) and HA-binding has been proven to participate in various biologic...

Full description

Bibliographic Details

Published in:	Cellular Physiology and Biochemistry
Main Authors:	Tang Liu, Zuyun Yan, Yong Liu, Edwin Choy, Francis J. Hornicek, Henry Mankin, Zhenfeng Duan
Format:	Article
Language:	English
Published:	Cell Physiol Biochem Press GmbH & Co KG 2018-04-01
Subjects:	Osteosarcoma CRISPR-Cas9 Meta-analysis CD44 Metastases Gene therapy
Online Access:	https://www.karger.com/Article/FullText/489072